Filter posts

Complexities of Rare Diseases Take the Spotlight at BIO

Global Genes Founder & CEO Nicole Boice opened the BIO 2015 Orphan & Rare Disease …

Outdated Payments Systems Aren’t Keeping Pace With Medical Innovation

We are experiencing an era of rapid medical progress thanks to the accelerated pace at …

NIH Director Francis Collins Opens Day Two at BIO International Convention

What happens when a hotel loses Francis Collins’ room reservation late on the eve before …

Expanding the Role of Patients in Drug Development

Working alongside scientists, universities, and biotech companies, patients and patient organizations have the ability to …

BIO 2015 Kicks Off: Patient-Focused Drug Development Key Theme of Day One

The BIO International Convention kicked off in Philadelphia today with a strong emphasis on patient-focused drug …

New Study: 340B Entities Not Using the Program as Intended

A new analysis released by Avalere Health and funded by the Alliance for Integrity and …

Time: How to Breathe New Life Into America's Health-Care System

Last week, Rep. Fred Upton (R-MI) published an op-ed – How to Breathe New Life Into America’s …

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About 'Big Pharma'

This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big …

BIO Applauds Energy and Commerce Health Subcommittee for Approving 21st Century Cures Act

Today, the Biotechnology Industry Organization (BIO) praises the Energy and Commerce Health Subcommittee for approving …

Tick Size Pilot Program: A Few Pennies Make a Big Difference

Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program …